Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bobby Lucero

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
European Journal of Medicinal Chemistry|February 1, 2019
1,2,4-Triazolo[1,5-a]pyrimidines in drug designKillian Oukoloff, Bobby Lucero, Karol R Francisco, et al.
Trends in Pharmacological Sciences|June 1, 2023
Protein-protein interactions: developing small-molecule inhibitors/stabilizers through covalent strategiesBobby Lucero, Karol R Francisco, Lawrence J Liu, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Photoaffinity labeling of protein targets in a complex metazoan: proof-of-concept using a probe for <i>Schistosoma mansoni</i> tubulinBobby Lucero, Thibault Alle, Marianna Bufano, et al.
Chemmedchem|January 26, 2024
Design, Synthesis, and Evaluation of An Anti-trypanosomal [1,2,4]Triazolo[1,5-a]pyrimidine Probe for Photoaffinity Labeling StudiesBobby Lucero, Karol R Francisco, Carmine Varricchio, et al.
Biorxiv : the Preprint Server for Biology|March 22, 2023
Structure-Activity Relationships, Tolerability and Efficacy of Microtubule-Active 1,2,4-Triazolo[1,5- <i>a</i> ]pyrimidines as Potential Candidates to Treat Human African TrypanosomiasisLudovica Monti, Lawrence J Liu, Carmine Varricchio, et al.
ACS Omega|August 19, 2024
Clickable Probes for Pathogen Proteasomes: Synthesis and ApplicationsLawrence J Liu, Bobby Lucero, Cindy Manriquez-Rodriguez, et al.
Chemmedchem|July 10, 2023
Structure-Activity Relationships, Tolerability and Efficacy of Microtubule-Active 1,2,4-Triazolo[1,5-a]pyrimidines as Potential Candidates to Treat Human African TrypanosomiasisLudovica Monti, Lawrence J Liu, Carmine Varricchio, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 17, 2024
A small-molecule microtubule-stabilizing agent safely reduces Aβ plaque and tau pathology in transgenic mouse models of Alzheimer's diseaseYuemang Yao, Megan Muench, Thibault Alle, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Structure-Activity Relationship and Target Investigation of Thiophen-2-yl-Pyrimidines against <i>Schistosoma</i> speciesKarol R Francisco, Bobby Lucero, Darius Yohannan, et al.
ACS Pharmacology & Translational Science|March 20, 2025
<i>d</i> <sub>4</sub>-Cystamine: A Deuterated Cystamine Derivative with Improved Anti-Inflammatory and Anti-Fibrotic Activities in a Murine Model of Fibrosing SteatohepatitisAleksandra Leszczynska, Thibault Alle, Benedikt Kaufmann, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
European Journal of Medicinal Chemistry|February 1, 2019
1,2,4-Triazolo[1,5-a]pyrimidines in drug designKillian Oukoloff, Bobby Lucero, Karol R Francisco, et al.
Trends in Pharmacological Sciences|June 1, 2023
Protein-protein interactions: developing small-molecule inhibitors/stabilizers through covalent strategiesBobby Lucero, Karol R Francisco, Lawrence J Liu, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Photoaffinity labeling of protein targets in a complex metazoan: proof-of-concept using a probe for <i>Schistosoma mansoni</i> tubulinBobby Lucero, Thibault Alle, Marianna Bufano, et al.
Chemmedchem|January 26, 2024
Design, Synthesis, and Evaluation of An Anti-trypanosomal [1,2,4]Triazolo[1,5-a]pyrimidine Probe for Photoaffinity Labeling StudiesBobby Lucero, Karol R Francisco, Carmine Varricchio, et al.
Biorxiv : the Preprint Server for Biology|March 22, 2023
Structure-Activity Relationships, Tolerability and Efficacy of Microtubule-Active 1,2,4-Triazolo[1,5- <i>a</i> ]pyrimidines as Potential Candidates to Treat Human African TrypanosomiasisLudovica Monti, Lawrence J Liu, Carmine Varricchio, et al.
ACS Omega|August 19, 2024
Clickable Probes for Pathogen Proteasomes: Synthesis and ApplicationsLawrence J Liu, Bobby Lucero, Cindy Manriquez-Rodriguez, et al.
Chemmedchem|July 10, 2023
Structure-Activity Relationships, Tolerability and Efficacy of Microtubule-Active 1,2,4-Triazolo[1,5-a]pyrimidines as Potential Candidates to Treat Human African TrypanosomiasisLudovica Monti, Lawrence J Liu, Carmine Varricchio, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 17, 2024
A small-molecule microtubule-stabilizing agent safely reduces Aβ plaque and tau pathology in transgenic mouse models of Alzheimer's diseaseYuemang Yao, Megan Muench, Thibault Alle, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Structure-Activity Relationship and Target Investigation of Thiophen-2-yl-Pyrimidines against <i>Schistosoma</i> speciesKarol R Francisco, Bobby Lucero, Darius Yohannan, et al.
ACS Pharmacology & Translational Science|March 20, 2025
<i>d</i> <sub>4</sub>-Cystamine: A Deuterated Cystamine Derivative with Improved Anti-Inflammatory and Anti-Fibrotic Activities in a Murine Model of Fibrosing SteatohepatitisAleksandra Leszczynska, Thibault Alle, Benedikt Kaufmann, et al.
Pageof 2